Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Incontinence and impotence occur following radical prostatectomy due to injury to nerves and sphincter muscle. Preserving nerves and muscle adjacent to prostate cancer risks positive surgical margins. Advanced imaging with MRI has improved cancer localization but limitations exist.
Objective: To measure the accuracy for assessing extra-prostatic extension at nerve bundles for 2 PSMA-PET tracers and to compare the PET accuracy to standard-of-care predictors including MRI and biopsy results.
Materials And Methods: We studied men with PSMA-targeted PET imaging, performed prior to prostatectomy in men largely with intermediate to high-risk prostate cancer, and retrospectively evaluated for assessment of extra-prostatic extension with whole-mount analysis as reference standard. Two different PSMA-PET tracers were included: Ga-PSMA-11 and Ga-P16-093. Blinded reviews of the PET and MRI scans were performed to assess extra-prostatic extension (EPE). Sensitivity and specificity for extra-prostatic extension were compared using McNemar's Chi.
Results: Pre-operative PSMA-PET imaging was available for 71 patients with either Ga-P16-093 (n = 25) or Ga-PSMA-11 (n = 46). There were 24 (34%) with pT3a (EPE) and 16 (23%) with pT3b (SVI). EPE Sensitivity (87% vs. 92%), Specificity (77% vs. 76%), and ROC area (0.82 vs. 0.84) were similar between P16-093 and PSMA-11, respectively (P = 0.87). MRI (available in only 45) found high specificity (83%) but low sensitivity (60%) for EPE when using a published grading system. MRI sensitivity was significantly lower than the PSMA-PET (60% vs. 90%, P = 0.02), but similar to PET when using a >5 mm capsular contact (76% vs. 90%, P = 0.38). A treatment change to "nerve sparing" was recommended in 21 of 71 (30%) patients based on PSMA-PET imaging.
Conclusions: Presurgical PSMA-PET appeared useful as a tool for surgical planning, changing treatment plans in men with ≥4+3 or multi-core 3+4 prostate cancer resulting in preservation of nerve-bundles.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.urolonc.2022.10.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of mpMRI and Ga-PSMA-PET/CT in the Assessment of the Primary Tumors in Predominant Low-/Intermediate-Risk Prostate Cancer.
Diagnostics (Basel)
May 2025
Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, 39120 Magdeburg, Germany.
While multi-parametric magnetic resonance imaging (mpMRI) is known to be a specific and reliable modality for the diagnosis of non-metastatic prostate cancer (PC), positron emission tomography (PET) using Ga labeled ligands targeting the prostate-specific membrane antigen (PSMA) is known for its reliable detection of prostate cancer, being the most sensitive modality for the assessment of the extra-prostatic extension of the disease and the establishment of a diagnosis, even before biopsy. : Here, we compared these modalities in regards to the localization of intraprostatic cancer lesions prior to local HDR brachytherapy. : A cohort of 27 patients received both mpMRI and PSMA-PET/CT.
View Article and Find Full Text PDFAssessing the influence of prostate tissue traits on Gallium-68 prostate-specific membrane-antigen positron-emission tomography/computed tomography: predictive factors for image positivity and locoregional recurrence in prostate cancer patients treated with radical prostatectomy and without prior or salvage treatment.
Prostate Int
March 2025
Department of Urology, Clinica Universidad de Navarra, University of Navarra, Pamplona, Spain.
Background: Gallium-68 prostate-specific membrane-antigen positron emission tomography/computed tomography (Ga-PSMA-11 PET/CT) has recently emerged as a novel imaging modality, potentially improving oncologic outcomes for prostate cancer patients. This study aimed to assess the potential predictive factors associated with Ga-PSMA-11 PET/CT positivity following persistent prostate-specific antigen (PSA) levels and primary biochemical recurrence post-radical prostatectomy (RP), focusing on prostate specimen characteristics. Furthermore, we aim to identify predictive factors for locoregional recurrence.
View Article and Find Full Text PDFComparative analysis of multiparametric prostate MRI and Ga-PSMA PET/MRI with radical prostatectomy specimens in prostate cancer staging.
Hell J Nucl Med
April 2025
Istanbul University - Cerrahpasa, Cerrahpasa Faculty of Medicine Department of Urology, Kocamustafapaşa Caddesi No:53 Cerrahpaşa 34098 Fatih / Istanbul, Turkey.
Objective: Because of low mortality rates and high treatment-related adverse effects in patients diagnosed early, active surveillance, focused treatments, and watchful waiting are currently advocated, emphasizing the importance of proper prostate cancer (Pca) staging using imaging techniques. We aimed to comparatively investigate the success rates of multiparametric prostate magnetic resonance imaging (MRI) and prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/MRI in predicting tumoral regions, seminal vesicle invasion, and extraprostatic extension.
Subjects And Methods: Twenty six patients with a biopsy diagnosis of prostate cancer who underwent radical prostatectomy between January 2021 and September 2022 were included in the study.
Prostate magnetic resonance imaging to predict grade concordance, extra prostatic extension, and biochemical recurrence after radical prostatectomy.
Urol Oncol
July 2025
Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, IL; Department of Urology, Loyola University Medical Center, Maywood, IL; Surgery Service, Jesse Brown VA Medical Center, Chicago, IL.
Objectives: To investigate whether preoperative prostate MRI findings predicted biopsy to radical prostate (RP) grade group concordance, presence of extraprostatic extension (EPE), and biochemical recurrence (BCR) after RP.
Material And Methods: We conducted a multi-institutional study (tertiary academic center and community practice) including patients who underwent RP (2014-2021) with preoperative MRI. Grade concordance for systematic, targeted, and combined prostate biopsy was compared to RP.
The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update.
Semin Nucl Med
May 2025
EJ Whitten Prostate Cancer Research Centre, Epworth Healthcare, Melbourne, Australia; Department of Urology, The Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia; University of Melbourne, Department of Surgery, Melbourne, Australia; Department of Cancer Surgery, Peter MacCallu
This review aims to provide an up-to-date overview of the utility of artificial intelligence (AI) in evaluating prostate-specific membrane antigen (PSMA) positron emission tomography (PET) scans for prostate cancer (PCa). A literature review was conducted on the Medline, Embase, Web of Science, and IEEE Xplore databases. The search focused on studies that utilizes AI to evaluate PSMA PET scans.
View Article and Find Full Text PDF